Ann: Appendix 4C and Quarterly Update, page-53

When yesterday I said money a third order issue I was obviously greatly exaggerating. It's an important issue, but it's still of secondary importance. More important (I think) is TIME. i think many including myself are sick to death of the we're gonna do this and we're gonna do that and then, sorry, another delay coz (fill in blank). We've stoically accepted the excuses, like the technical difficulties of fabricating an mTOR drug (when you look at the history of mTOR projects) and more recently the pandemic issues, but these delays have hurt confidence and this is reflected in the low capital value for a biotech at this stage of the program in such (what we think) a promising and unique type of medication. Sure, part of it was the poor to zero marketing like NZT said, especially earlier on, but the delays are hurting confidence.